Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity. [electronic resource]
- Vaccine Mar 2009
- 1511-22 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0264-410X
10.1016/j.vaccine.2009.01.014 doi
Animals Antibodies, Viral--biosynthesis Capsid Proteins--genetics Cell Line Drug Contamination--prevention & control Endotoxins--immunology Escherichia coli--genetics Female Human papillomavirus 16--genetics Humans Mice Mice, Inbred C57BL Oncogene Proteins, Viral--genetics Papillomavirus Infections--immunology Papillomavirus Vaccines--genetics Recombinant Proteins--genetics T-Lymphocytes, Cytotoxic--immunology Uterine Cervical Neoplasms--immunology